Antibodies specific for CD3 and uses thereof
PH12020552006B1Active Publication Date: 2026-07-31PFIZER INC
0 Cites 0 Cited by
Patent Information
- Application Number
- PH12020552006
- Authority / Receiving Office
- PH · PH
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2020-11-23
- Publication Date
- 2026-07-31
- Estimated Expiration
- 2040-11-23
Abstract
The present invention provides novel antibodies that specifically bind to CD3 and uses thereof. The invention also provides therapeutic and diagnostic methods utilizing the antibodies and antigen-binding fragments provided herein.
Need to check novelty before this filing date? Find Prior Art